These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 25525179)

  • 1. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
    Mishima E; Fukuda S; Shima H; Hirayama A; Akiyama Y; Takeuchi Y; Fukuda NN; Suzuki T; Suzuki C; Yuri A; Kikuchi K; Tomioka Y; Ito S; Soga T; Abe T
    J Am Soc Nephrol; 2015 Aug; 26(8):1787-94. PubMed ID: 25525179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.
    Mishima E; Fukuda S; Kanemitsu Y; Saigusa D; Mukawa C; Asaji K; Matsumoto Y; Tsukamoto H; Tachikawa T; Tsukimi T; Fukuda NN; Ho HJ; Kikuchi K; Suzuki C; Nanto F; Suzuki T; Ito S; Soga T; Tomioka Y; Abe T
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F824-F833. PubMed ID: 29167170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
    Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
    Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
    Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huang Gan Formula Alleviates Systemic Inflammation and Uremia in Adenine-Induced Chronic Kidney Disease Rats May Associate with Modification of Gut Microbiota and Colonic Microenvironment.
    Zhao J; Zhao C; Xun T; Wang X; Wei S; Ye C; Zhang M; Guo D; Yang X
    Drug Des Devel Ther; 2024; 18():13-28. PubMed ID: 38205394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lubiprostone for chronic constipation in adults.
    Drug Ther Bull; 2014 Apr; 52(4):42-4. PubMed ID: 24722574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbial and short-chain fatty acid profiles in adults with chronic constipation before and after treatment with lubiprostone.
    Kang DW; DiBaise JK; Ilhan ZE; Crowell MD; Rideout JR; Caporaso JG; Rittmann BE; Krajmalnik-Brown R
    Anaerobe; 2015 Jun; 33():33-41. PubMed ID: 25617726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Phenylheptanoic Acid-Hydroxypropyl β-Cyclodextrin Complex Slows the Progression of Renal Failure in Adenine-Induced Chronic Kidney Disease Mice.
    Commey KL; Enaka A; Nakamura R; Yamamoto A; Tsukigawa K; Nishi K; Otagiri M; Yamasaki K
    Toxins (Basel); 2024 Jul; 16(7):. PubMed ID: 39057956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
    Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
    Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: a case series.
    O'Brien CE; Anderson PJ; Stowe CD
    Ann Pharmacother; 2010 Mar; 44(3):577-81. PubMed ID: 20179256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.
    Yang CY; Chen TW; Lu WL; Liang SS; Huang HD; Tseng CP; Tarng DC
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.